Drug Shortage Report for DIMENHYDRINATE INJECTION USP

Last updated on 2018-05-16 History
Report ID 39961
Drug Identification Number 02435241
Brand name DIMENHYDRINATE INJECTION USP WITH PRESERVATIVE
Common or Proper name Dimenhydrinate Injection USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) DIMENHYDRINATE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 5 ML
ATC code R06AA
ATC description ANTIHISTAMINES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-02-01
Estimated end date 2018-05-10
Actual end date 2018-05-10
Shortage status Resolved
Updated date 2018-05-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2018-02-15 English Compare
v1 2018-02-15 English Compare

Showing 21 to 22 of 22